Company / Accounts Receivable
Perspective Therapeutics, Inc. Accounts Receivable History
FY2013-FY2022 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Accounts Receivable
$1.4M
FY2022
5-year range
$1.4M / $1.4M
FY2018-FY2022
Trend
-
vs FY2021
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Improved from $913,049 to $1M over the past 8 years.
Based on SEC 10-K filings.
$1M in FY2022.
Improved from $913,049 to $1M over the past 8 years.
Accounts Receivable over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 5.43 (safe zone, above 2.9 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Accounts ReceivableValue | YoY GrowthYoY |
|---|---|---|
| FY2022 | $1.4M | - |
| FY2021 | - | - |
| FY2020 | - | - |
| FY2019 | - | - |
| FY2018 | - | - |
| FY2017 | - | - |
| FY2016 | - | - |
| FY2015 | $1.0M | +14.9% |
| FY2014 | $913.0K | -1.2% |
| FY2013 | $923.8K | - |
As of FY2022 · SEC 10-K · Updated Jun 24, 2026